XML 49 R39.htm IDEA: XBRL DOCUMENT v3.25.2
Shareholders' Equity and Share-Based Payments - Time Based Stock Options with market based exercisability conditions (Details) - MSOs
3 Months Ended 9 Months Ended
Jun. 16, 2025
D
$ / shares
Jun. 30, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
D
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Shareholders' Equity and Share-Based Payments        
Vesting period     4 years  
Exercise price | $ / shares     $ 8.59  
Targeted market percentage     15.00%  
Options exercisable at the end of the period (in dollars per share) | $ / shares $ 9.88   $ 9.88  
Threshold consecutive trading days | D 20   20  
Common stock per award     1  
Grant date fair value of options | $     $ 474,998  
Weighted-average grant date fair value (in dollars per share) | $ / shares     $ 4.51  
Contractual Term     10 years  
Share-based compensation expense | $   $ 85,111   $ 98,757
Unrecognized compensation cost, related to non-vested stock options | $   $ 376,243   $ 376,243
Vested (in shares)   0   0
Forfeited (in shares)   0   0
Chief Executive Officer        
Shareholders' Equity and Share-Based Payments        
Grant of vested stock options     72,062  
Chief Financial Officer        
Shareholders' Equity and Share-Based Payments        
Grant of vested stock options     33,259  
Tranche one        
Shareholders' Equity and Share-Based Payments        
Vesting percentage     25.00%  
Tranche two        
Shareholders' Equity and Share-Based Payments        
Vesting percentage for each quarter     6.25%  
Tranche three        
Shareholders' Equity and Share-Based Payments        
Vesting percentage for each quarter     6.25%  
Tranche four        
Shareholders' Equity and Share-Based Payments        
Vesting percentage for each quarter     6.25%  
Minimum        
Shareholders' Equity and Share-Based Payments        
Vesting period     1 year  
Maximum        
Shareholders' Equity and Share-Based Payments        
Vesting period     4 years